Xiao-Wen Yu (Xiaowen Yu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Estrogen Receptor

Top Venues

EMBO molecular medicine

Environmental toxicology

Science translational medicine

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine (2024)
Jun Qin, Yingying Zhao, Shumin Li, Qian-Qi Liu, Songming Huang, Xiao-Wen Yu
GDH1 exacerbates renal fibrosis by inhibiting the transcriptional activity of peroxisome proliferator-activated receptor gamma. The FEBS journal (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Shumin Li, Jun Qin, Yingying Zhao, Jiali Wang, Songming Huang, Xiao-Wen Yu
Tubular insulin-induced gene 1 deficiency promotes NAD + consumption and exacerbates kidney fibrosis. EMBO molecular medicine 16 (7) (2024)
Hui Yuan, Yingying Zhao, Shumin Li, Jun Qin, Xiao-Wen Yu
Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway. Environmental toxicology (2023)
Hui Yuan, Yingying Zhao, Shumin Li, Jun Qin, Xiao-Wen Yu
Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway. Environmental toxicology (2023)
Hui Yuan, Yingying Zhao, Shumin Li, Jun Qin, Xiao-Wen Yu
Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway. Environmental toxicology (2023)
Hui Yuan, Yingying Zhao, Shumin Li, Jun Qin, Xiao-Wen Yu
Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway. Environmental toxicology (2023)
Xiao-Wen Yu, Man Xu, Xia Meng, Shumin Li, Qian-Qi Liu, Mi Bai, Ran You, Songming Huang, Li Yang, Yue Zhang, Zhanjun Jia, Aihua Zhang
Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI. Science translational medicine 12 (543) (2021)
Xiao-Wen Yu, Yue Zhang, Zhanjun Jia, Aihua Zhang
Response to comment on "Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI". Science translational medicine 13 (593) (2021)
Xiao-Wen Yu, Dandan Wei, Ying-Sheng Gao, Hong-Zhi Du, Bo-Yang Yu, Rui-Ming Li, Chang-Min Qian, Xue-Jun Luo, Sheng-Tao Yuan, Jun-Song Wang, Li Sun
Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis. Journal of cellular and molecular medicine 23 (10) (2019)